- Home
- ACA vs APLS Comparison
ACA vs APLS Comparison
Compare ACA & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACA
- APLS
- Stock Information
- Founded
- ACA 2018
- APLS 2009
- Country
- ACA United States
- APLS United States
- Employees
- ACA N/A
- APLS N/A
- Industry
- ACA Metal Fabrications
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- ACA Industrials
- APLS Health Care
- Exchange
- ACA Nasdaq
- APLS Nasdaq
- Market Cap
- ACA 4.8B
- APLS 4.0B
- IPO Year
- ACA N/A
- APLS 2017
- Fundamental
- Price
- ACA $100.81
- APLS $30.13
- Analyst Decision
- ACA Strong Buy
- APLS Buy
- Analyst Count
- ACA 4
- APLS 18
- Target Price
- ACA $105.50
- APLS $46.71
- AVG Volume (30 Days)
- ACA 231.0K
- APLS 2.1M
- Earning Date
- ACA 02-20-2025
- APLS 02-25-2025
- Dividend Yield
- ACA 0.20%
- APLS N/A
- EPS Growth
- ACA N/A
- APLS N/A
- EPS
- ACA 2.63
- APLS N/A
- Revenue
- ACA $2,485,900,000.00
- APLS $715,216,000.00
- Revenue This Year
- ACA $13.83
- APLS $95.82
- Revenue Next Year
- ACA $13.89
- APLS $12.02
- P/E Ratio
- ACA $38.25
- APLS N/A
- Revenue Growth
- ACA 11.68
- APLS 162.10
- 52 Week Low
- ACA $72.75
- APLS $24.34
- 52 Week High
- ACA $113.43
- APLS $71.90
- Technical
- Relative Strength Index (RSI)
- ACA 54.51
- APLS 44.83
- Support Level
- ACA $96.48
- APLS $27.61
- Resistance Level
- ACA $98.92
- APLS $30.13
- Average True Range (ATR)
- ACA 2.22
- APLS 1.50
- MACD
- ACA 0.56
- APLS -0.35
- Stochastic Oscillator
- ACA 91.60
- APLS 33.82
About ACA Arcosa Inc.
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.